News

Deal Announcements

Genapsys Lands New Venture Capital Equity

Monday, March 25, 2013 5:32:00 AM PDT | VentureDeal
   Redwood City, California  --  Biotechnology company Genapsys has secured $8.5 million in new venture capital equity financing, according to an SEC filing.

Genapsys is developing what it calls "cost disruptive, easy to use genomic diagnostic systems... that deliver 100x improvement in cost and speed."

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Genapsys is still seeking $5 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1